London · Delayed Price · Currency is GBP · Price in GBX Ovoca Bio Statistics
Total Valuation
Ovoca Bio has a market cap or net worth of GBP 937,984. The enterprise value is -1.54 million.
| Market Cap | 937,984 |
| Enterprise Value | -1.54M |
Important Dates
The last earnings date was Wednesday, June 25, 2025.
| Earnings Date | Jun 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ovoca Bio has 81.56 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 81.56M |
| Shares Outstanding | 81.56M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 45.90% |
| Owned by Institutions (%) | n/a |
| Float | 44.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2.50 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.47
| Current Ratio | 4.47 |
| Quick Ratio | 4.32 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.13% and return on invested capital (ROIC) is -6.82%.
| Return on Equity (ROE) | -0.13% |
| Return on Assets (ROA) | -5.08% |
| Return on Invested Capital (ROIC) | -6.82% |
| Return on Capital Employed (ROCE) | -12.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -616,919 |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.78% in the last 52 weeks. The beta is 0.63, so Ovoca Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +27.78% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 0.85 |
| Average Volume (20 Days) | 8,666 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -205,915 |
| Pretax Income | -2,481 |
| Net Income | -616,919 |
| EBITDA | 42,175 |
| EBIT | -205,915 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 2.07 million in cash and n/a in debt, giving a net cash position of 2.07 million or 0.03 per share.
| Cash & Cash Equivalents | 2.07M |
| Total Debt | n/a |
| Net Cash | 2.07M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 1.70M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.70M |
Cash Flow
| Operating Cash Flow | -939,438 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ovoca Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | n/a |
| Earnings Yield | -65.77% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 18, 2010. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jan 18, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |